IM Cannabis Corp. Overview
Pro stress-test →IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company recently exited operations in Canada to pivot focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany.
Strategic Profile
Pro stress-test →IM Cannabis leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. The company operates medical cannabis retail pharmacies, online platforms, and distribution centers in Israel, and in Germany distributes cannabis to pharmacies through Adjupharm GmbH, which also offers fulfillment services using its EU-GMP packing facility and GDP logistics center.
Competitive Landscape
Pro stress-test →IM Cannabis provides medical cannabis dried flowers and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company operates in highly regulated medical cannabis markets in Israel and Germany, competing primarily with other licensed cultivators and distributors in these jurisdictions.
Industry Context
IM Cannabis Corp. operates in Medical Cannabis Manufacturing & Distribution.
Key facts
Founded: 2008 · Headquarters: Tel Aviv, Israel